Abstract: A battery cover latch mechanism includes a housing, a battery cover, and a latching part. The housing includes a clasp positioned thereon. The battery cover includes a guiding portion and a resisting block facing the guiding portion. The latching part includes a button and a resilient bar assembled on the battery cover. The button includes a hook resisting the resisting block. The button slidably and releasably latches to the clasp to lock the battery cover to the housing or release the battery cover from the housing. The invention also discloses a portable electronic device using the battery cover latch mechanism.

Abstract: A battery cover latch mechanism includes a housing, a battery cover, and a latching part. The housing includes a clasp positioned thereon. The battery cover includes a guiding portion and a resisting block facing the guiding portion. The latching part includes a button and a resilient bar assembled on the battery cover. The button includes a hook resisting the resisting block. The button slidably and releasably latches to the clasp to lock the battery cover to the housing or release the battery cover from the housing. The invention also discloses a portable electronic device using the battery cover latch mechanism.

Abstract: The invention provides novel GlyT2 inhibiting compounds useful in modulating, treating, or preventing: anxiolytic disorders; a condition requiring treatment of injured mammalian nerve tissue; a condition amenable to treatment through administration of a neurotrophic factor; a neurological disorder; or obesity; an obesity-related disorder.

Abstract: Antibacterial compounds, compositions containing them, and methods of use for the inhibition of bacterial activity and the treatment, prevention or inhibition of bacterial infection.

Abstract: An optical system for a laser level is described. The laser level comprises at least two optical systems which are parallel to and oppositely adjoin to each other in a same plane. Each optical system comprises a laser light source, a regular lens, a diffusion lens, a beam-splitting element, and an outer casing as well as the regular lens and the diffusion lens are located between the laser light source and the beam-splitting element. For the optical system of the laser level, the laser beam is sequentially regularized, diffused and split into a fan-shaped light beam with an angle greater than 180 degrees to ensure that the light beams from the optical systems are spread in the same plane. Thus, the laser level generates a disk-shaped light beam with 360 degrees to indicate a circular mark in the same plane.

Abstract: Certain ?-, ?-, and ?-amino acid derivatives are disclosed as selective GlyT2 inhibitors for the treatment of central nervous system (CNS) conditions such as muscle spasticity, tinnitus, epilepsy and neuropathic pain.

Abstract: The invention provides novel GlyT2 inhibiting compounds useful in modulating, treating, or preventing: anxiolytic disorders; a condition requiring treatment of injured mammalian nerve tissue; a condition amenable to treatment through administration of a neurotrophic factor; a neurological disorder; or obesity; an obesity-related disorder.